Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases

J. Soukup, M. Manethova, H. Faistova, L. Krbal, B. Vitovcova, H. Hornychova, J. Drugda, T. Cesak, D. Netuka, F. Gabalec, A. Ryska

. 2022 ; 81 (6) : 799-807. [pub] 20220922

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032430

Pitx2 is a transcription factor responsible for establishment of the right-left axis and development of the gut and pituitary. In mouse embryos, Pitx2 is expressed in the greater curvature of the stomach and midgut. Previously, Pitx2 was studied in pituitary neuroendocrine tumours but not in other NETs. Pitx2 expression was immunohistochemically assessed in whole sections and tissue microarrays in a cohort of 224 neuroendocrine neoplasms, and was analysed in 29 cases. The cohort included 18 cauda equina NETs, 38 paragangliomas, 98 cases of primary visceral NETs from different organs, 23 metastases of visceral NETs and 47 neuroendocrine carcinomas (NECs). Pitx2 expression was observed in 29.5% (29 of 98) NETs and 14.9% (7 of 47) NECs, but was not observed in any paraganglioma or cauda equina NET. Pitx2 was observed only in tumours of midgut-derived organs, including the small intestine (100%, 20 of 20), appendix (88.9%, eight of nine) and large intestine (9.1%, one of 11 - only caecal NET). The NETs of remaining locations were negative. Pitx2 was 96.7% sensitive and 100% specific for NETs of midgut origin. In NECs, Pitx2 positivity was observed in goblet cell adenocarcinoma (75%, three of four), medullary thyroid carcinoma (42.9, three of seven) and one Merkel cell carcinoma (25%, one of four). In metastatic NETs, Pitx2 was observed in all the tumours originating in the small intestine (n = 17) or caecum (n = 1). No positivity was observed in tumours from other locations (four pancreas, one lung). We observed no correlation between immunoreactivity and mRNA expression. Thus, Pitx2 immunohistochemistry can be helpful in assessing the midgut origin of NETs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032430
003      
CZ-PrNML
005      
20230308115356.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/his.14789 $2 doi
035    __
$a (PubMed)36089904
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Soukup, Jiri $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic $1 https://orcid.org/0000000171694386
245    10
$a Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases / $c J. Soukup, M. Manethova, H. Faistova, L. Krbal, B. Vitovcova, H. Hornychova, J. Drugda, T. Cesak, D. Netuka, F. Gabalec, A. Ryska
520    9_
$a Pitx2 is a transcription factor responsible for establishment of the right-left axis and development of the gut and pituitary. In mouse embryos, Pitx2 is expressed in the greater curvature of the stomach and midgut. Previously, Pitx2 was studied in pituitary neuroendocrine tumours but not in other NETs. Pitx2 expression was immunohistochemically assessed in whole sections and tissue microarrays in a cohort of 224 neuroendocrine neoplasms, and was analysed in 29 cases. The cohort included 18 cauda equina NETs, 38 paragangliomas, 98 cases of primary visceral NETs from different organs, 23 metastases of visceral NETs and 47 neuroendocrine carcinomas (NECs). Pitx2 expression was observed in 29.5% (29 of 98) NETs and 14.9% (7 of 47) NECs, but was not observed in any paraganglioma or cauda equina NET. Pitx2 was observed only in tumours of midgut-derived organs, including the small intestine (100%, 20 of 20), appendix (88.9%, eight of nine) and large intestine (9.1%, one of 11 - only caecal NET). The NETs of remaining locations were negative. Pitx2 was 96.7% sensitive and 100% specific for NETs of midgut origin. In NECs, Pitx2 positivity was observed in goblet cell adenocarcinoma (75%, three of four), medullary thyroid carcinoma (42.9, three of seven) and one Merkel cell carcinoma (25%, one of four). In metastatic NETs, Pitx2 was observed in all the tumours originating in the small intestine (n = 17) or caecum (n = 1). No positivity was observed in tumours from other locations (four pancreas, one lung). We observed no correlation between immunoreactivity and mRNA expression. Thus, Pitx2 immunohistochemistry can be helpful in assessing the midgut origin of NETs.
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    12
$a neuroendokrinní nádory $x metabolismus $7 D018358
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    12
$a neuroendokrinní karcinom $x patologie $7 D018278
650    _2
$a imunohistochemie $7 D007150
650    12
$a paragangliom $7 D010235
650    12
$a nádory kůže $7 D012878
655    _2
$a časopisecké články $7 D016428
700    1_
$a Manethova, Monika $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Faistova, Hana $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Krbal, Lukas $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Vitovcova, Barbora $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Hornychova, Helena $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Drugda, Jan $u 4th Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic $7 xx0283088
700    1_
$a Cesak, Tomas $u Department of Neurosurgery, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Netuka, David $u Department of Neurosurgery and Neurooncology, First Medical Faculty, Charles University, Military University Hospital Prague, Prague, Czech Republic
700    1_
$a Gabalec, Filip $u 4th Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Ryska, Ales $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic
773    0_
$w MED00002043 $t Histopathology $x 1365-2559 $g Roč. 81, č. 6 (2022), s. 799-807
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36089904 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230308115352 $b ABA008
999    __
$a ok $b bmc $g 1891283 $s 1183765
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 81 $c 6 $d 799-807 $e 20220922 $i 1365-2559 $m Histopathology $n Histopathology $x MED00002043
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace